USPTO serial 79254156
360 BIOLABS
Reviewed by CopyMark Law Group
Reg. 5841881Status 706Registered
- Filing date
- Status date
- Registration date
- Aug 27, 2019
- Examiner
- LATTUCA, FRANK J
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with 360 BIOLABS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ashley N. Klein
Ashley N. Klein Bradley Arant Boult Cummings LLP1230 Peachtree Street NE, Suite 2100Promenade TowerAtlanta, GA 30309Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and technological services and research and design relating thereto for the development of therapeutic, medicinal, pharmaceutical, vaccination, immunotherapy and diagnostic technology and products; design and development services, namely, design and development of new therapeutic, medicinal, pharmaceutical, vaccination, immunotherapy and diagnostic technology and products; laboratory analysis and research in the field of therapeutic, medical, pharmaceutical, vaccination, [ immunothrapy ] * immunotherapy * and diagnostic technology and products; quality assurance services in the field of the design and development of therapeutic, medical, pharmaceutical, vaccination, immunotherapy and diagnostic technology and products; testing, analysis and evaluation of the goods of others to determine conformity with certification standards; quality control for others; laboratory testing services in the field of therapeutic, medical, pharmaceutical, vaccination, immunotherapy and diagnostic [ thechnoloty ] * technology * and products; conducting clinical trials for others; biological research; development services in the field of therapeutic, medicinal, pharmaceutical, vaccination, immunotherapy and diagnostic technology and products; advisory and consultancy services in the field of the design, development and research of therapeutic, medicinal, pharmaceutical, vaccination, immunotherapy and diagnostic technology and products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 7, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 7, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Oct 7, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Oct 6, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 30, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 27, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 2, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 13, 2020 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jul 5, 2020 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 10, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 21, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 21, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 27, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 5, 2019 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| Nov 4, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 4, 2019 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Aug 27, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 11, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 11, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 22, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 6, 2019 | ALIE | ASSIGNED TO LIE | — |
| Apr 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 16, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 12, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 28, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 27, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 21, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 18, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 17, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 17, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 14, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |